MV

Maksims Vlasenko

Active Director Director DIN 11531144
DIN 11531144 First appointment Feb 2026 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Feb 2026
Shareholding value β€’β€’β€’β€’ Premium profile

About Maksims Vlasenko

Data last updated:

Maksims Vlasenko is a Director at Globalluxrx Laboratories Private Limited (since 2026). The company operates in Pharma.

DIN 11531144
Primary Designation Director
Industry Pharma
First Appointment 07 Feb 2026

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director07 Feb 20262026Active

Board colleagues of Maksims Vlasenko

NameDINCompanyDesignation
Pravin Ekanath Patil09787906Globalluxrx Laboratories Private LimitedDirector

Directorship timeline

Open interactive timeline →
Globalluxrx Laboratories Private Limited
Premium access

Shareholding and investment profile for Maksims Vlasenko

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Maksims Vlasenko

Maksims Vlasenko currently holds 1 directorship: Globalluxrx Laboratories Private Limited (Director, since 07 Feb 2026).

Maksims Vlasenko was first appointed on 07 Feb 2026 as Director at Globalluxrx Laboratories Private Limited.

The current boards of Maksims Vlasenko's companies include Pravin Ekanath Patil (Globalluxrx Laboratories Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available